Abstract
Population aging is now a global phenomenon. This shift in society’s age structure has been a gradual process in developed countries, spanning over more than a century. In more developing regions, however, population aging has only recently begun and is proceeding at a much faster pace than it did in developed countries (Kinsella and Phillips 2005).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Notes
- 1.
We use the terms ‘lifespan extension’ and ‘anti-aging’ interchangeably throughout this chapter.
- 2.
Although we have previously argued that a lifespan of 1000 years is highly unrealistic, we have chosen to stick to Harris’ example in order to offer an accurate representation of his argument.
- 3.
The term ‘longevity dividend’ is generally used to refer to these other benefits as well as to the expected benefit of healthcare savings.
References
Atzmon, G., T.I. Pollin, J. Crandall, K. Tanner, C.B. Schechter, P.E. Scherer et al. 2008. Adiponectin levels and genotype: A potential regulator of lifespan in humans. The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences 63(5): 447–453.
Baur, J.A. 2010. Resveratrol, sirtuins, and the promise of a DR mimetic. Mechanisms of Aging and Development 131(4): 261–269.
Beard, R.L., and J.B. Williamson. 2010. Social policy and the internal dynamics of the senior rights movement. Journal of Aging Studies 25(1): 22–33.
Binstock, R.H. 2004. Anti-aging medicine and research: A realm of conflict and profound societal implications. The Journals of Gerontology Series A: Biological Sciences and Medical Sciences 59(6): B523–533.
Bostrom, N., and R. Roache. 2008. Ethical Issues in Human Enhancement. In New Waves in Applied Ethics, eds. T. Petersen, J. Ryberg, and C. Wolf 120–152. Hampshire, UK: Palgrave Macmillan.
Butler, R.N., R. Sprott, H. Warner, J. Bland, R. Feuers, M. Forster et al. 2004. Aging: The reality. Biomarkers of aging: From primitive organisms to humans. The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences 59(6): B560–567.
Butler, R.N., R.A. Miller, D. Perry, B.A. Carnes, T.F. Williams, C. Cassel et al. 2008. New model of health promotion and disease prevention for the 21st century. British Medical Journal 337(7662): 149–150.
Callahan, D. 1987. Setting Limits. Medical goals in an aging society.Washington, DC: Georgetown University Press.
Callahan, D. 2009. Taming the beloved beast: How medical technology costs are destroying our healthcare system. Princeton: Princeton University Press.
Callahan, D., and K. Prager. 2008. Medical care for the elderly: Should limits be set? Virtual Mentor. American Medical Association Journal of Ethics 10(6): 404–410.
Cannon, M. 2011. Ryan budget: A huge opportunity to improve healthcare. Kaiser health news. http://www.kaiserhealthnews.org/Columns/2011/April/040411cannon.aspx. Accessed 10 May 2011.
Caplan, A.L. 2005. Death as an unnatural process. Why is it wrong to seek a cure for aging? EMBO Reports 6(special issue 1): S72–75.
Coory, M.D. 2004. Aging and healthcare costs in Australia: A case of policy-based evidence? Medical Journal of Australia 180(11): 581–583.
Daniels, N. 1988. Am I my parents’ keeper? An essay on justice between the young and the old. New York: Oxford University Press.
de Grey, A.D. 2005. Life extension, human rights, and the rational refinement of repugnance. Journal of Medical Ethics 31(11): 659–663.
de Grey, A. D. 2006. Compression of morbidity: The hype and the reality, Part 1. Rejuvenation Research 9(1): 1–2.
de Grey, A.D., B.N. Ames, J.K. Andersen, A. Bartke, J. Campisi, C.B. Heward et al. 2002. Time to talk SENS: Critiquing the immutability of human aging. Annals of the New York Academy of Sciences 959: 452–462.
Derkx, P. 2009. Life Extension and Meanings of Life. In Technology, Trust, and Religion: Roles of Religions in Controversies on Ecology and the Modification of Life, ed. W. Drees 197–220. Amsterdam: Leiden University Press.
Dorshkind, K., E. Montecino-Rodriguez., and R.A Signer. 2009. The aging immune system: Is it ever too old to become young again? Nature Reviews Immunology 9(1): 57–62.
Ehni, H.J., and G. Marckmann. 2009. Social justice, health inequities, and Access to new age-related interventions. Medicine Studies 1(3): 281–295.
Estep III, P., M. Kaeberlein, P. Kapahi, B. Kennedy, G. Lithgow, G. Martin, S. Melov et al. 2006. Life extension pseudoscience and the SENS Plan. Technology Review (MIT). http://www.technologyreview.com/sens/docs/estepetal.pdf. Accessed 05 May 2011.
Farrelly, C. 2008. Has the time come to take on time itself? British Medical Journal 337(7662): 147–148.
Fishman, J.R., R.H. Binstock., and M.A. Lambrix. 2008. Anti-aging science: The emergence, maintenance, and enhancement of a discipline. Journal of Aging Studies 22(4): 295–303.
Fleck, L.M. 2010. Just caring: In defense of limited age-based healthcare rationing. Cambridge Quarterly of Healthcare Ethics 19(1): 27–37.
Franceschi, C., D. Monti, P. Sansoni., and A Cossarizza. 1995. The immunology of exceptional individuals: the lesson of centenarians. Immunology Today 16(1): 12–16.
Gems, D. 2009. Eine revolution des alterns. Die neue biogerontologie und ihre implikationen. In Länger leben? Philosophische und biowissenschaftliche Perspektiven, eds. S. Knell, and M. Weber 25–45. Frankfurt am Main: Surhkamp Verlag.
Gems, D. 2011. Tragedy and delight: The ethics of decelerated aging. Philosophical transactions of the royal society B: Biological Sciences 366(1561): 108–112.
Geyman, J.P. 2004. Privatization of medicare: Toward disentitlement and betrayal of a social contract. International Journal of Health Services 34(4): 573–594.
Giordano, S. 2005. Respect for equality and the treatment of the elderly: Declarations of human rights and age-based rationing. Cambridge Quarterly of Healthcare Ethics 14(1): 83–92.
Gonos, E.S. 2000. Genetics of aging: Lessons from centenarians. Experimental Gerontology 35(1): 15–21.
Hackler, C. 2004. Extending the lifespan: Mythic desires and modern dangers. HEC Forum 16(3): 182–196.
Hadley, E.C., E.G. Lakatta, M. Morrison-Bogorad, H.R. Warner., and R.J. Hodes. 2005. The future of aging therapies. Cell 120(4): 557–567.
Harris, J. 1985. The value of life: An introduction to medical ethics. London: Routledge and Kegan Paul.
Harris, J. 2004. Immortal ethics. Annals of the New York Academy of Sciences 1019: 527–534.
Holliday, R. 1996. The urgency of research on aging. BioEssays 18(2): 89–90.
Ingram, D.K., R.M. Anson, R. de Cabo, J. Mamczarz, M. Zhu, J. Mattison et al. 2004. Development of calorie restriction mimetics as a prolongevity strategy. Annals of the New York Academy of Sciences 1019: 412–423.
Juengst, E.T., R.H. Binstock, M. Mehlman, S.G. Post., and P. Whitehouse. 2003. Biogerontology, “anti-aging medicine,” and the challenges of human enhancement. Hastings Center Report 33(4): 21–30.
Kinsella, K., and D. Phillips. 2005. Global aging: The challenge of success. Population Reference Bureau. http://prb.org/pdf05/60.1GlobalAging.pdf. Accessed 14 Apr 2011.
Lang, F.R., P.B. Baltes., and G.G. Wagner. 2007. Desired lifetime and end-of-life desires across adulthood from 20–90: A dual-source information model. The Journals of Gerontology, Series B: Psychological Sciences and Social Sciences 62(5): 268–276.
Lee, M. 2006. Is BC’s healthcare system sustainable? A closer look at the costs of aging and technology. Canadian Centre for Policy Alternatives. http://www.policyalternatives.ca/sites/default/files/uploads/publications/BC_Office_Pubs/bc_2006/aging_healthcare.pdf. Accessed 03 June 2011.
Levinsky, N.G. 1990. Age as a criterion for rationing healthcare. The New England Journal of Medicine 322(25): 1813–1816.
Louria, D.B. 2005. Extraordinary longevity: individual and societal issues. Journal of the American Geriatrics Society 53(9 Suppl): S317–319.
Mackey, T. 2003. An ethical assessment of anti-aging medicine. Journal of Anti-Aging Medicine 6(3): 187–204.
Marmor, T., and J. Oberlander. 1998. Rethinking medicare reform. Health Affairs 17(1): 52–68.
Micans, P. 2005. The need for anti-aging medicine: The challenges faced to incorporate preventative medicine into the clinic and into society. Annals of the New York Academy of Sciences 1057(1): 545–562.
Miller, R.A. 2002. Extending life: scientific prospects and political obstacles. Milbank Quarterly 80(1): 155–174.
Olshansky, S.J., D. Perry, R.A. Miller., and R.N. Butler. 2006. In Pursuit of the longevity dividend: What should we be doing to prepare for the unprecedented aging of humanity? The Scientist 20(3): 28–33.
Partridge, B., J. Lucke, H. Bartlett., and W. Hall. 2011. Public attitudes towards human life extension by intervening in aging. Journal of Aging Studies 25(2): 73–83.
Richardson, J., and I. Robertson. 1999. Aging and the cost of health services. Working Paper 90. Centre for Health Program Evaluation.http://www.buseco.monash.edu.au/centres/che/pubs/wp90.pdf. Accessed 15 June 2011.
Sprott, R.L. 2010. Biomarkers of aging and disease: Introduction and definitions. Experimental Gerontology 45(1): 2–4.
Underwood, M., H.P. Bartlett, B. Partridge, J. Lucke., and W.D. Hall. 2009. Community perceptions on the significant extension of life: An exploratory study among urban adults in Brisbane, Australia. Social Science & Medicine 68(3): 496–503.
Vincent, J.A., E. Tulle., and J. Bond. 2008. The anti-aging enterprise: Science, knowledge, expertise, rhetoric and values. Journal of Aging Studies 22(4): 291–294.
Warner, H., J. Anderson, S. Austad, E. Bergamini, D. Bredesen, R. Butler et al. 2005. Science fact and the SENS agenda. EMBO reports 6(11): 1006–1008.
Wickstrøm, J., N. Serup-Hansen., and I.S. Kristiansen. 2002. Future healthcare costs–do healthcare costs during the last year of life matter? Health Policy 62(2): 161–172.
Wiener, J.M., and J. Tilly. 2002. Population aging in the United States of America: Implications for public programmes. International Journal of Epidemiology 31(4): 776–781.
Zhang, Y., and F. Goza. 2006. Who will care for the elderly in China? A review of the problems caused by China’s one child policy and their potential solutions. Journal of Aging Studies 20(2): 151–164.
Zweifel, P., S. Felder., and A. Werblow. 2004. Population aging and healthcare expenditure: New evidence on the “red herring”. Geneva Papers on Risk and Insurance—Issues and Practice 29(4): 652–666.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Capitaine, L., Pennings, G. (2013). Biogerontology: A Promising Route to Cost Containment in Healthcare?. In: Schermer, M., Pinxten, W. (eds) Ethics, Health Policy and (Anti-) Aging: Mixed Blessings. Ethics and Health Policy, vol 1. Springer, Dordrecht. https://doi.org/10.1007/978-94-007-3870-6_19
Download citation
DOI: https://doi.org/10.1007/978-94-007-3870-6_19
Published:
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-007-3869-0
Online ISBN: 978-94-007-3870-6
eBook Packages: MedicineMedicine (R0)